Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.60
+0.05 (0.26%)
At close: Mar 13, 2026

Daiken Biomedical Revenue

In the year 2025, Daiken Biomedical had annual revenue of 1.90B TWD with 39.10% growth. Daiken Biomedical had revenue of 656.11M in the quarter ending December 31, 2025, with 20.63% growth.

Revenue
1.90B
Revenue Growth
+39.10%
P/S Ratio
8.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.90B532.70M39.10%
Dec 31, 20241.36B171.97M14.45%
Dec 31, 20231.19B305.45M34.52%
Dec 31, 2022884.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition